Amsterdam, Netherlands

Soizic Porhel

This inventor holds 6 USPTO granted patents. Top assignee: Gilead Sciences, Inc.. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Soizic Porhel. Retrieved from https://idiyas.com/inventor/soizic-porhel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 83.3

Average Co-Inventor Count = 18.0

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2022-2026

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Soizic Porhel: Innovator in Pharmaceutical Packaging

Introduction

Soizic Porhel is a prominent inventor based in Amsterdam, Netherlands. She has made significant contributions to the field of pharmaceutical packaging, holding a total of five patents. Her innovative work has garnered attention in the industry, particularly for its potential to enhance the safety and efficacy of pharmaceutical products.

Latest Patents

Among her latest patents is a groundbreaking pharmaceutical package designed to improve the delivery and preservation of medications. This invention reflects her commitment to advancing healthcare solutions through innovative packaging technologies.

Career Highlights

Soizic Porhel is currently employed at Gilead Sciences, Inc., a leading biopharmaceutical company. Her role at Gilead allows her to collaborate with other experts in the field and contribute to the development of cutting-edge pharmaceutical products.

Collaborations

Throughout her career, Soizic has worked alongside notable colleagues, including Benjamin Luke Kozub and Brian Nilstoft. These collaborations have further enriched her experience and expanded her impact within the pharmaceutical industry.

Conclusion

Soizic Porhel is a trailblazer in pharmaceutical packaging, with a strong portfolio of patents and a commitment to innovation. Her work continues to influence the industry and improve patient outcomes through enhanced medication delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…